Delayed-release Niacin Benefits Prediabetes, Diabetes
Delayed-release Niacin may be beneficial to patients with prediabetes and type 2 diabetes.
Diagnosis & Disease Information
Pre-Op Liraglutide Reduces Post-Op Plasma Glucose in Diabetes Pts
In patients with T2DM, taking liraglutide before surgery may be associated with reduced post-op plasma glucose levels.
FDA Approves Short Acting Insulin Drug for Diabetes
The FDA just approved a new short-acting insulin drug, Admelog, for patients with either T1D or T2D.
Primary Care-led Weight Loss Leads to T2DM Remission
Remission was linked to 46% patients in intensive weight management programs.
FDA Approves Semiglutide for Type 2 Diabetes
Semaglutide helps patients with diabetes reduce blood glucose levels and lower body weight.
Antibiotic-Diabetes Link Questioned
Lifestyle and clinical factors could have been misinterpreted, linking antibiotics to risk of diabetes.
Greater Adherence With Certain Type 2 Diabetes Meds
Sulfonylureas and thiazolidinediones adherence was stronger than metformin adherence.
Diabetic CKD Patients Survive Longer With Metformin
Diabetic patients with chronic kidney disease starting treatment with metformin have a 36% decreased risk of death compared with those starting on a sulfonylurea, study finds.
Hypertension, Diabetes at Hemodialysis Initiation Increasing
From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.
NODAT Risk Similar After Switching From CNIs to Everolimus
The incidence of NODAT was 33.8% among patients who switched to everolimus and 36.4% among those who stayed on calcineurin inhibitors.
- Loading...
Loading...
Next post in ATC 2017
Loading... 
Loading...